Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment
Clinical trial NCT05484375 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05484375
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.